Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Pramlintide & Type 2 diabetes (T2D), insulin (medication) + pramlintide received approval from the U.S. Food and Drug Administration on March 16, 2005. It is intended for use as an adjunct to mealtime insulin in patients with both type 1 and type 2 diabetes who have not achieved adequate glycemic control despite optimized insulin therapy. For individuals with Type 2 diabetes, it is specifically indicated for those on mealtime insulin, whether or not they are also taking metformin and/or sulfonylurea, to enha…